SCI Science Perspectives American Spinal Injury Association

Join us in this episode for a panel conversation on nontraumatic spinal cord injury (SCI) with Alexandra Bennewith, MPA, Keara McNair, OTR/L, BCPR, ATP, Kristen Walden, BS, Ron Reeves, MD, and Stephen Burns, MD. Paralysis due to problem in the spinal cord come can come from many causes, and historically an emphasis has been placed on traumatic—like from an impact—SCI. As put forth by this panel of nontraumatic experts selected by ASIA's Education Committee, the time has come to integrate nontraumatic SCI into the existing networks of standardized reporting. The panelists discuss expert consensus, best practices, and future directions for classifying and tracking outcomes as to deliver better care for people living nontraumatic SCI. We hope you enjoy this episode as we usher in an era in the union of SCI regardless of cause.

Join us in this episode for a panel conversation on expert consensus, best practices, and future directions for classifying and tracking outcomes for people living with nontraumatic spinal cord injury (SCI) with Alexandra Bennewith, MPA, Keara McNair, OTR/L, BCPR, ATP, Kristen Walden, BS, Ron Reeves, MD, and Stephen Burns, MD. Disorders of the spinal cord come in many forms, and when categorizing based on cause there has historically been an emphasis placed on traumatic—e.g., from an impact—SCI. As put forth by this panel of nontraumatic experts selected by ASIA's Education Committee, the time has come to integrate nontraumatic SCI into the existing networks of standardized reporting. We hope you enjoy this episode as we usher in an era in the union of SCI across etiology.

Join us this episode for a conversation with Dr. Sina Sangari of the Shirley Ryan AbilityLab for a conversation about the paper titled "Spasticity Predicts Motor Recovery for Patients with Subacute Motor Complete Spinal Cord Injury" published in the journal Annals of Neurology. Regardless of the functional implications of spasms, Dr. Sangari and his colleagues explain the predictive value that spasticity, early after an acquired spinal cord injury, can have in predicting recovery of volitional motor function. We hope you enjoy this scholarly episode that offers a fresh take on the classic topic of spasticity.

Join us this episode for a conversation with Dr. Sina Sangari of the Shirley Ryan AbilityLab for a conversation about the paper titled "Spasticity Predicts Motor Recovery for Patients with Subacute Motor Complete Spinal Cord Injury" published in the journal Annals of Neurology. Regardless of the functional implications of spasms, Dr. Sangari and his colleagues explain the prognostic value that spasticity, early after an acquired spinal cord injury, can have in predicting recovery of volitional motor function. We hope you enjoy this scholarly episode that offers a fresh take on the classic topic of spasticity.

Join us this episode for a conversation with Dr. Parag Gad, co-founder and CEO of SpineX, for a conversation about the Spinal Cord Neuromodulator by SpineX and Scone to Treat Neurogenic Bladder, or the SCONE “CONTINENCE” Clinical trial (https://www.clinicaltrials.gov/study/NCT05301335). Dr. Gad talks gives a brief history on SpineX, the scientific inspiration for the current neuromodulation trial targeting incontinence, and visions for the company's future commercial targets. This episode on a neuromodulatory device targeting urinary function was recorded in collaboration with our friends at Bladder Buzz, (in our opinion) the podcast on neurogenic bladder that "brings together physicians, researchers, and individuals living with neurogenic bladder" (https://bladderbuzzpodcast.buzzsprout.com/). We hope you enjoy this collab episode with Dr. Gad from SpineX.

Join us this episode for a conversation with Dr. Parag Gad, co-founder and CEO of SpineX, for a conversation about the Spinal Cord Neuromodulator by SpineX and Scone to Treat Neurogenic Bladder, or the SCONE “CONTINENCE” Clinical trial (https://www.clinicaltrials.gov/study/NCT05301335). Dr. Gad talks gives a brief history on SpineX, the scientific inspiration for the current neuromodulation trial targeting incontinence, and visions for the company's future commercial targets. This episode on a neuromodulatory device targeting urinary function was recorded in collaboration with our friends at Bladder Buzz, (in our opinion) the podcast on neurogenic bladder that "brings together physicians, researchers, and individuals living with neurogenic bladder" (https://bladderbuzzpodcast.buzzsprout.com/). We hope you enjoy this collab episode with Dr. Gad from SpineX.